Integrating High-Throughput Chromatography and Data Science in a Platform for the  Rapid and Accurate Quantification of Full, Partial, and Empty AAV Capsids

Propose a platform to streamline the design of chromatographic methods for quantifying gene-loaded (full), partially loaded (partial), and empty Adeno-Associated Virus (AAV) capsids.
Categories
Cell and Gene therapies
Process control
Project status
19% Completed

Industry Need

The success of AAV-based gene therapies relies on bioprocess technologies that can produce high-purity, cell-transducing capsids at clinically relevant scales. However, current expression systems generate a mix of full, partial, and empty capsids, whose proportions vary with serotype, transgene, and process conditions, posing safety risks such as immunogenicity and genotoxicity. Removing these impurities requires a complex anion-exchange chromatography (AEX) enrichment step, which must be tailored to specific AAV designs and sample characteristics. Developing effective AEX protocols is challenging due to numerous interdependent parameters, including stationary phase properties, flow rates, buffer compositions, and elution formats.

Solution

To address the challenges in AAV capsid purification, this project will leverage the combined expertise and resources of NIIMBL academic and industry partners, including advanced chromatographic technologies, modeling tools, and a diverse library of model AAVs. We will establish the Platform for Analytical Chromatographic Testing (PACT) to rapidly screen and validate AEX protocols across varied AAV designs, generating a comprehensive dataset of in-line, at-line, and off-line analytics. This data will inform the development of the Rulebook of AAV Analytical Chromatography (RAAC), a predictive framework linking chromatographic parameters to capsid purity outcomes. Together, PACT and RAAC will transform AEX method development from empirical trial-and-error to a systematic, data-driven approach, accelerating gene therapy manufacturing and supporting NIIMBL’s broader data initiatives.

Outputs/Deliverables

  • A comprehensive document detailing the technical specifications and a thorough description of the methodologies employed in data generation.

Impacts

Additional Project Information (Members Only)

Login to the NIIMBL member portal to access more, including: 

  • Updates
  • Value Proposition
  • Related Publications
  • Deliverables

Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.

Project Lead

North Carolina State University

North Carolina State University

Participating Organizations

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.

Bristol-Myers Squibb

Bristol-Myers Squibb

Chromagenix

Chromagenix

EMD Millipore Corporation

EMD Millipore Corporation

Joan & Sanford I. Weill Medical College of Cornell University

Joan & Sanford I. Weill Medical College of Cornell University

Refeyn Inc.

Refeyn Inc.

Rensselaer Polytechnic Institute

Rensselaer Polytechnic Institute

Sartorius Stedim

Sartorius Stedim

University of Florida

University of Florida